© Copyright Acquisition International 2025 - All Rights Reserved.

Article Image - Venture Capital Dollars Invested in Life Sciences Companies in 2014 at Highest Level Since 2007
Posted 12th March 2015

Venture Capital Dollars Invested in Life Sciences Companies in 2014 at Highest Level Since 2007

Venture capitalists invested US$2.8bn in life sciences in the fourth quarter, reaching US$8.6bn in 2014, according to MoneyTree Report from PwC.

Mouse Scroll AnimationScroll to keep reading

Let us help promote your business to a wider following.

Venture Capital Dollars Invested in Life Sciences Companies in 2014 at Highest Level Since 2007
Image

Venture Capital Dollars Invested in Life Sciences Companies in 2014 at Highest Level Since 2007

Venture capitalists invested US$2.8bn in life sciences in the fourth quarter, reaching US$8.6bn in 2014, according to MoneyTree Report from PwC

Venture capital (VC) funding for the Life Sciences sector – Biotechnology and Medical Devices – increased 49% in dollars but declined 18% in deals during the fourth quarter of 2014, compared to fourth quarter of 2013, according to the MoneyTree™ Report from PricewaterhouseCoopers (PwC) LLP and the National Venture Capital Association (NVCA), based on data provided by Thomson Reuters. The report, entitled “Biotech funding surges,” shows that VCs invested US$2.8bn in 202 Life Sciences deals during the quarter, versus US$1.9bn going into 245 deals in the fourth quarter of 2013 and US$1.7bn in 197 deals during the previous quarter in 2014.

Overall, investments for full year 2014 in the Life Sciences sector rose to the highest level since 2007 with US$8.6bn invested into 789 deals, a 29% increase in dollars but a 3% drop in deals compared to 2013. Biotechnology investment dollars rose 29% compared to 2013 to US$6.0bn, while the number of deals decreased 4% to 470 deals, making it the second largest investment sector for the year in terms of dollars invested, behind the Media and Entertainment sector. The Medical Devices industry finished 2014 up 27% in dollars to US$2.7bn, and the number of deals remained relatively flat in 2014, compared to 2013.

“The life sciences sector saw five megadeals last year, a testament to the highly innovative biotech and medical device technologies and the resulting confidence of venture capitalists in the business models of these start-ups,” said Greg Vlahos, Life Sciences partner at PwC. “The biotechnology industry attracted record-high venture investments in the second quarter of 2014 and ended the year with even higher investments in the fourth quarter. In addition, the medical device industry continued to show strong growth for the year. This is in line with PwC’s projection in early 2014 of a very strong year for life sciences. Given the strong level of investments in this sector and others in recent quarters, we expect continued high investment levels in life sciences in the first half of 2015.”

First-Time vs. Follow-On Funding

Investments into Life Sciences companies receiving VC investment for the first time in Q4 2014 totalled US$403m – an increase of 35% from the same quarter in the prior year. Life Sciences follow-on funding in the fourth quarter of 2014 surged 51% year over year to US$2.4bn. In fact, follow-on funding for the Life Sciences sector and Biotechnology industry during the quarter achieved the highest level since 1995, when MoneyTree began reporting VC investing levels. For the full year 2014, first-time funding in the Life Sciences sector was US$1.1bn and follow-on funding was US$7.5bn, representing growth of 25% and 29%, respectively. For the full year, first-time deals in the sector averaged US$7.3m and follow-on funding deals averaged US$11.8m.

Funding by Subsegment

When compared to the fourth quarter of 2013, five of the seven Biotechnology subsegments that received investment rose during the fourth quarter of 2014. The biotech-human subsegment captured the largest share of Biotechnology funding, increasing 46% to US$1.7bn compared to the first quarter of 2013. In addition, pharmaceutical increased 60% to US$115m; biotech equipment rose 148% to US$100m; biotech research saw a slight 1% increase to US$39m; while biosensor investments increased 259% to US$28m. The two biotechnology subsegments that saw a decrease in funding in the fourth quarter compared with the same period last year were biotech-animal, down 64% to US$10m and biotech-industrial, declining 74% to US$7m.

Funding for each of the three Medical Device subsegments increased during the fourth quarter of 2014 compared to the same quarter in 2013, including medical therapeutics up 8% to US$368m; medical/health products rising 170% to US$201m and medical diagnostics increasing 216% to US$180m.

Investments by Region

During the fourth quarter of 2014, Boston, Chicago, the San Francisco Bay Area, New York Metro and Research Triangle received the most Life Sciences venture capital dollars. Boston, the leader of the five regions, received US$959m in funding for 32 deals during the quarter, with US$928m going into biotechnology and the remaining US$31m invested in medical devices. The San Francisco Bay Area captured US$839m, New York Metro received US$175m, Research Triangle accumulated US$127m and Chicago rounded the list with US$90m invested.

In 2014, total venture capital dollars invested in the U.S. across all industries was US$48.3bn, including US$14.8bn in the fourth quarter – the highest annual and quarterly investment totals since 2000. “The strong IPO market has played a big role in this robust performance of venture funding, and there are good signs that the trend has legs that can carry it well into 2015,” Vlahos continued. “With a 33% increase in funding for early-stage life sciences companies in 2014, start-ups are likely to continue to do well in the year ahead.”

Categories: Finance


You Might Also Like
Read Full PostRead - Eye Icon
Industrial Businesses: Lowering Costs To Better Your Bottom Line
Finance
27/09/2022Industrial Businesses: Lowering Costs To Better Your Bottom Line

Starting up and maintaining your industrial business to be profitable is a challenge. The start up costs are some of the highest for any industry, with the highest costs associated with purchasing and maintaining equipment. 

Read Full PostRead - Eye Icon
Alibaba Group Signs Strategic Agreement With Shanghai Media Group
Strategy
04/06/2015Alibaba Group Signs Strategic Agreement With Shanghai Media Group

Alibaba Group Holding Limited announced today it has signed a strategic agreement with Shanghai Media Group

Read Full PostRead - Eye Icon
Large Sum Buys and Payments Abroad: How to Reduce Associated Fees
Finance
25/04/2022Large Sum Buys and Payments Abroad: How to Reduce Associated Fees

Buying an expensive item abroad may not sound like a logical go-to in the wake – or the midst, depending on your position – of a global pandemic. Supply chains have been chewed up, with worker and truck driver shortages, along with a microprocessor

Read Full PostRead - Eye Icon
Mountain Capital Acquires Zep
M&A
15/04/2015Mountain Capital Acquires Zep

Zep Inc. Enters into Definitive Agreement to Be Acquired by New Mountain Capital

Read Full PostRead - Eye Icon
How Common Are Office Injuries – And What Can You Do About Them?
Legal
31/05/2022How Common Are Office Injuries – And What Can You Do About Them?

Being an office worker may not be amongst the riskiest professions, but an office environment can present a range of hazards which often result in harm. But what can you do if you’ve been injured at work?

Read Full PostRead - Eye Icon
Lloyds Blueprint Two: How Third-Party Data and Software Providers Can Help the Insurance Sector to Release This Value
News
16/01/2023Lloyds Blueprint Two: How Third-Party Data and Software Providers Can Help the Insurance Sector to Release This Value

The Lloyds of London insurance market is inarguably one of the world’s oldest and least modernised groups and it is having to re-think the way it interacts with customers and turning to digital. This is a prime example for the rest of the sector that it is t

Read Full PostRead - Eye Icon
Building a Successful Upskilling Strategy
Strategy
21/12/2020Building a Successful Upskilling Strategy

How can businesses better support L&D in their organisations and build effective upskilling strategies to remain competitive?

Read Full PostRead - Eye Icon
Haskell Acquires Leidos Constructors and Design Assets
M&A
16/03/2016Haskell Acquires Leidos Constructors and Design Assets

Haskell, one of the leading fully integrated design, engineering and construction firms, announced today that it has signed a definitive agreement to acquire Leidos Constructors, LLC.

Read Full PostRead - Eye Icon
What You Could Be Losing Out On By Not Using Hotel Revenue Management Technology
Strategy
17/11/2020What You Could Be Losing Out On By Not Using Hotel Revenue Management Technology

Several factors such as holidays, weekends, competitor rates, and other market conditions are taken into consideration for predicting the price of a hotel room. A hotel revenue management system will analyse the correct rate at which your hotel rooms should be



Our Trusted Brands

Acquisition International is a flagship brand of AI Global Media. AI Global Media is a B2B enterprise and are committed to creating engaging content allowing businesses to market their services to a larger global audience. We have 14 unique brands, each of which serves a specific industry or region. Each brand covers the latest news in its sector and publishes a digital magazine and newsletter which is read by a global audience.

Arrow